SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Pump Mind Virus is a Pure Meme with a long term vision. We are building for the future while making no promises about the present. The project aims to bring the spirit of community memes back to the Solana ecosystem. We do that with engaging content and memes. Culture through community. Viral spread by word of mouth.  And most importantly, by not using the fake hype machine that has come to dominate the meme coin landscape.

PumpMindVirus

PumpMindVirus ($PMV) is trending as its community rallies around its "infection" narrative and meme culture, creating a fun and energetic atmosphere. Community members highlight the coin's strong team and organic growth, with many mentioning that fading this coin would be a mistake. The coin, which originated on $PUMP on $SOL, is focused on spreading its infectious memes.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta (KTA) is trending due to community excitement around its potential as foundational infrastructure for TradFi, emphasized by its high throughput and compliance-aware design. Investors are actively discussing the token's value proposition in comparison to major platforms like Amazon, Google, and Microsoft, viewing KTA as a targeted bet on the future of financial plumbing. The community also highlights potential partnerships, particularly with Stripe, as a key catalyst.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

SLV is trending as silver prices approach all-time highs, fueled by expectations of a potential Federal Reserve rate cut and strong demand for safe-haven assets. The community is discussing the possibility of a silver squeeze and potential triple-digit prices, citing increased industrial demand and a potential supply shortage. Some traders suggest watching gold's movements for cues, while others believe a pullback is imminent.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

Compound (COMP) is seeing increased community discussion as traders speculate about potential catalysts for a price surge, with some highlighting a possible partnership and others pointing to governance-related developments. Some traders are expressing frustration with COMP's price action compared to other cryptocurrencies and are weighing its prospects against competitors like AAVE. The overall sentiment suggests a mix of hope for future growth and concern about current performance.

MLN is the official token of Enzyme. Founded in 2017, Enzyme is the global infrastructure for tokenized finance. Enzyme provides industry leaders with a comprehensive suites of Vault-As-A-Service and Financial Instruments products to manage on-chain assets efficiently, optimize operational processes, and develop innovative financial strategies tailored to their unique goals and challenges.

Melon

Enthusiasm surrounds MLN as traders discuss its potential for significant upward movement, drawing comparisons to other tokens that have experienced substantial rallies. Community members are actively monitoring technical indicators and volume, anticipating a breakout. Some speculate that the project's low supply and market cap could contribute to a rapid price increase.

First Majestic Silver Corp. engages in the production, development, exploration and acquisition of mineral properties. It owns and operates producing mines in México including the La Encantada Silver Mine, La Parrilla Silver Mine, San Martin Silver Mine, La Guitarra Silver Mine, Del Toro Silver Mine, Santa Elena Silver & Gold Mine, and San Dimas Silver & Gold Mine. The company was founded by Keith Neumeyer on September 26, 1979 and is headquartered in Vancouver, Canada.

First Majestic Silver Corporation

First Majestic Silver is trending as silver prices surge, hitting fresh all-time highs, which has sparked discussions about potential breakouts and leveraged gains for silver miners. The community is weighing whether to take profits or hold for further upside, with some anticipating a significant squeeze in silver markets. Broader discussions include comparing AG to other silver stocks and analyzing technical charts for potential price movements.

SMX (Security Matters) Plc is a holding company, which engages in the provision of authentication solutions. It offers brand protection, authentication, and track and trace technology. The company was founded by Haggai Alon on July 1, 2022 and is headquartered in Dublin, Ireland.

SMX (Security Matters) Plc

SMX (Security Matters) PLC

SMX is trending due to a recent surge in price, fueled by multiple press releases about its technology for global trade security and its presentation at a precious metals conference in Dubai. Community discussions revolve around the potential for a short squeeze, high borrowing rates for shorting, and speculation about the company's ties to Dubai and the gold market. Concerns persist about potential dilution and the stock's history of reverse splits.

Verrica Pharmaceuticals, Inc. is a dermatology therapeutics company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its products include Pipeline VP-102, Pipeline VP-103, and Pipeline VP-315. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.

Verrica Pharmaceuticals Inc

VRCA is trending due to positive investor sentiment around its potential as a low-float biotech mover, with discussions focusing on insider confidence and potential for significant gains on catalysts. Community members are actively discussing its history of explosive moves and recent private placement, while acknowledging both the opportunities and risks associated with the stock. Some traders point to recent gains and trading strategies around the stock.

Got that dog in you? - Fueled by a mantra of tokenized self-belief, doginme is representative of the community's collective efforts to embrace and embolden that dog in them. doginme stands for knowing yourself and having that unshakable drive to keep pushing forward. doginme was originally launched in February 2024 when the Farcaster founder was asked if he owned a dog, to which he replied affirmatively: "no but I got that dog in me"

doginme

Doginme is trending as the community rallies around positive chart setups and bullish order book activity, anticipating a breakout soon. Traders are discussing the coin's potential for a December run, citing stable BTC and increasing buyer momentum. The community emphasizes that the current levels may not be seen again, with some members drawing comparisons to previous meme coin cycles.

Next Technology Holding, Inc. engages in the provision of software development services to the customers and bitcoin acquisition. The company was founded on March 28, 2019 and is headquartered in Shenzhen, China.

Next Technology Holding Inc.

NXTT is trending due to a recent Nasdaq update regarding its listing status and speculation surrounding its significant Bitcoin holdings, which some believe positions it for substantial gains. The community is actively discussing the potential for a short squeeze and comparing it to other high-flying stocks, while also debating the validity of its Bitcoin reserves and upcoming catalysts like the hearing.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sana Biotechnology (NASDAQ:SANA) Trading 12.8% Higher - Still a Buy?

Sana Biotechnology (NASDAQ:SANA) Shares Up 12.8% - Still a Buy...

Sana Biotechnology (NASDAQ:SANA) Stock Rating Lowered by Wall Street Zen

Wall Street Zen lowered shares of Sana Biotechnology from a "hold" rating to a "sell" rating in a research report on Saturday...

Sana Biotechnology, Inc. (NASDAQ:SANA) Given Average Rating of "Moderate Buy" by Brokerages

Sana Biotechnology, Inc. (NASDAQ:SANA - Get Free Report) has been given an average rating of "Moderate Buy" by the nine brokerages that are covering the company, Marketbeat Ratings reports. One...

Sana Biotechnology (NASDAQ:SANA) Shares Down 7.1% - Time to Sell?

Sana Biotechnology (NASDAQ:SANA) Trading Down 7.1% - Here's What Happened...

Top 3 Genomics Stocks to Consider for Your Portfolio

Genomics gains momentum as EDIT, SANA, and PACB emerge as standout picks amid rapid advances in sequencing and gene editing.

Sana Biotechnology (NASDAQ:SANA) Trading Up 9.2% - Should You Buy?

Sana Biotechnology (NASDAQ:SANA) Stock Price Up 9.2% - What's Next...

All You Need to Know About Sana (SANA) Rating Upgrade to Buy

Sana (SANA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Sana Biotechnology (NASDAQ:SANA) Upgraded to Hold at Wall Street Zen

Wall Street Zen upgraded shares of Sana Biotechnology from a "sell" rating to a "hold" rating in a research report on Saturday...

Wedbush Forecasts Strong Price Appreciation for Sana Biotechnology (NASDAQ:SANA) Stock

Wedbush upped their price target on shares of Sana Biotechnology from $5.00 to $6.00 and gave the company an "outperform" rating in a report on Friday...

Sana Biotechnology (NASDAQ:SANA) Given New $9.00 Price Target at HC Wainwright

HC Wainwright lowered their price target on Sana Biotechnology from $11.00 to $9.00 and set a "buy" rating on the stock in a research note on Friday...

Sana Biotechnology, Inc. engages in the research and development of engineered cells as medicine. It focuses on identifying and developing potential product candidates, executing preclinical studies, and acquiring technology. The company was founded by Steven D. Harr, Noubar B. Afeyan, Robert Taylor Nelsen, and Hans Edgar Bishop on July 2018 and is headquartered in Seattle, WA.

Sana Biotechnology Inc

$AMZN

$MSFT

$GOOGL

$ORCL

Which cloud infrastructure stock offers the best long-term opportunity right now?

SANA
Sana Biotechnology Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest SANA News

SANASana Biotechnology Inc